Adenovirus-mediated expression of Tob1 sensitizes breast cancer cells to ionizing radiation

Acta Pharmacologica Sinica

Volumn 28, Issue 10, 2007, Pages 1628-1636

  Jiao, Yang ^a   Ge, Chun Min ^b   Meng, Qing Hui ^a   Cao, Jian Ping ^a   Tong, Jian ^a   Fan, Sai Jun ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Breast cancer; Radiation; Radiosensitivity; Tob1

Indexed keywords

ADENOVIRUS VECTOR; KU ANTIGEN; PROTEIN; PROTEIN BAX; TOB1 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASSAY; BREAST CANCER; CANCER CELL; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DOWN REGULATION; EMBRYO; GEL ELECTROPHORESIS; GENE EXPRESSION; HOST CELL REACTIVATION ASSAY; HUMAN; HUMAN CELL; IONIZING RADIATION; NICK END LABELING; PROTEIN EXPRESSION; RADIOSENSITIVITY; UPREGULATION; WESTERN BLOTTING; X RAY;

ADENOVIRIDAE; ANTIGENS, NUCLEAR; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CESIUM RADIOISOTOPES; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; FEMALE; GENETIC VECTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; RADIATION, IONIZING; RADIATION-SENSITIZING AGENTS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 34848886040     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00647.x     Document Type: Article

References (34)

1. Kufe D, Weichselbaum R. Radiation therapy: activation for gene transcription and the development of genetic radiotherapy-therapeutic strategies in oncology. Cancer Biol Ther 2003 2 : 326 9.
2. Robson T, Worthington J, McKeown SR, Hirst DG. Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity. Technol Cancer Res Treat 2005 4 : 343 61.
3. Freyta SO, Kim JH, Brown SL, Barton K, Lu M, Chung M. Gene therapy strategies to enhance the effectiveness of cancer radiotherapy. Curr Opin Mol Ther 2004 6 : 513 24.
4. Lumniczky K, Safrany G. Cancer gene therapy: combination with radiation therapy and the role of bystander cell killing in the anti-tumor effect. Pathol Oncol Res 2006 12 : 118 24.
5. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002 23 : 687 96.
6. Han Z, Wang H, Hallahan DE. Radiation-guided gene therapy of cancer. Technol Cancer Res Treat 2006 5 : 437 44.
7. Ferguson DO, Alt FW. DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene 2001 20 : 5572 9.
8. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002 109 (Suppl S45 55.
9. Matsuda S, Kawamura-Tsuzuku J, Ohsugi M, Yoshida M, Emi M, Nakamura Y, et al. Tob, a novel protein that interacts with p185 erbB2, is associated with anti-proliferative activity. Oncogene 1996 12 : 705 13.
10. Suzuki T, K-Tsuzuku J, Ajima R, Nakamura T, Yoshida Y, Yamamoto T. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev 2002 16 : 1356 70.
11. Yoshida Y, Nakamura T, Komada M, Satoh H, Suzuki T, Tsuzuku JK, et al. Mice lacking a transcriptional corepressor Tob are predisposed to cancer. Genes Dev 2003 17 : 1201 6.
12. Ito Y, Suzuki T, Yoshida H, Tomoda C, Uruno T, Takamura Y, et al. Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid. Cancer Lett 2005 220 : 237 42.
13. Yanagie H, Sumimoto H, Nonaka Y, Matsuda S, Hirose I, Hanada S, et al. Inhibition of human pancreatic cancer growth by the adenovirus-mediated introduction of a novel growth suppressing gene, tob, in vitro. Adv Exp Med Biol 1998 451 : 91 6.
14. Sasajima H, Nakagawa K, Yokosawa H. Antiproliferative proteins of the BTG/Tob family are degradated by the ubiquitin-proteasome system. Eur J Biochem 2002 269 : 3596 604.
15. Hiramatsu Y, Kitagawa K, Suzuki T, Uchida C, Hattori T, Kikuchi H, et al. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res 2006 66 : 8477 83.
16. Xia F, Powell SN. The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer. Semin Radiat Oncol 2002 12 : 296 304.
17. Suzuki T, Tsuzuku JK, Ajima R, Nakamura T, Yoshida Y, Yamamoto T. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev 2002 16 : 1356 70.
18. Cho HN, Lee YJ, Cho CK, Lee SJ, Lee YS. Downregulation of ERK2 is essential for the inhibition of radiation-induced cell death in HSP25 overexpressed L929 cells. Cell Death Differ 2002 9 : 448 56.
19. Kawate H, Wu Y, Ohnaka K, Nawata H, Takayanagi R. Tob proteins suppress steroid hormone receptor-mediated transcrip-tional activation. Mol Cell Endocrinol 2005 230 : 77 86.
20. Toillon RA, Magne N, Laios I, Lacroix M, Duvillier H, Lagneaux L, et al. Interaction between estrogen receptor alpha, ionizing radiation and (anti-) estrogens in breast cancer cells. Breast Cancer Res Treat 2005 93 : 207 15.
21. Paulsen GH, Strickert T, Marthinsen AB, Lundgren S. Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta Oncol 1996 35 : 1011 9.
22. Fan S, Wang J, Ma Y, Yuan R, Meng Q, Erdos M, et al. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 2001 22 : 77 87.
23. Fan S, Wang J, Yuan R, Rockwell S, Andres J, Zlatapolskiy A, et al. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA damaging-agents. Oncogene 1998 17 : 131 41.
24. Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 2005 103 : 1551 60.
25. Walensky LD. BCL-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ 2006 13 : 1339 50.
26. Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001 26 : 61 6.
27. Thomadaki H, Scorilas A. BCL-2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit Rev Clin Lab Sci 2006 43 : 1 67.
28. Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 2005 103 : 1551 60.
29. Rainbow AJ. Repair of radiation-induced DNA breaks in human adenovirus. Radiat Res 1974 60 : 155 64.
30. Featherstone C, Jackson SP. Ku, a DNA repair protein with multiple cellular functions Mutat Res 1999 434 : 3 15.
31. Tuteja R, Tuteja N. Ku autoantigen: a multifunctional DNA-binding protein. Crit Rev Biochem Mol Biol 2000 35 : 1 33.
32. Kurimasa A, Ouyang H, Dong LJ, Wang S, Li X, Cordon-Cardo C, et al. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc Natl Acad Sci USA 1999 96 : 1403 8.
33. Nussenzweig A, Chen C, da Costa Soares V, Sanchez M, Sokol K, Nussenzweig MC, et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature (Lond) 1996 382 : 551 5.
34. Ouyang H, Nussenzweig A, Kurimasa A, Soares VC, Li X, Cordon-Cardo C, et al. Ku70 is required for DNA repair but not for TCR gene recombination in vivo. J Exp Med 1997 186 : 921 9.